Causes of Death in Patients with Laryngeal Cancer in Stages I and II
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293 |
Resumo: | Background: Laryngeal carcinoma is one of the most common cancers in the head and neck region and occurs predominantly in males. The peak of incidence is between 50 and 70 years of life. The glottis is the most affected topography, but in the Mediterranean countries the supraglottic region assumes a particular preponderance. In the early stages of the disease, the survival rate at 5 years is of about 90% (stage I). The most important risk factors for this tumor are alcohol and tobacco consumption and these patients, probably because of their lifestyle, have several associated comorbidities. Objectives: To frame the survival rates related to the disease, not disease related and also those arising from other malignancies, allowing to criticize some published data. Methods: From the analysis of medical records of patients diagnosed with laryngeal cancer in stages I and II, treated from 2000 to 2005, the cause of death in these patients was analysed. Results: A total of 216 clinical records were reviewed. It was observed that the overall survival of patients in the study period was 75% and that 66.7% and 54.5% of the deaths were not related to the disease, respectively, for stages I and II. It was also found that the specific survival rate for stage I was 94.6% and for stage II was 90.3%. Conclusion: The results show that most patients’ deaths were not related to laryngeal cancer. Thus, the authors emphasize the importance of a careful analysis of statistical data on rates of survival / mortality for cancers of the larynx, especially in the early stages. |
id |
RCAP_d5ac5e46e86b7565ae7a089afa71798d |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/293 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Causes of Death in Patients with Laryngeal Cancer in Stages I and IICausas de Morte nos Doentes com Neoplasia da Laringe nos Estádios I e IIBackground: Laryngeal carcinoma is one of the most common cancers in the head and neck region and occurs predominantly in males. The peak of incidence is between 50 and 70 years of life. The glottis is the most affected topography, but in the Mediterranean countries the supraglottic region assumes a particular preponderance. In the early stages of the disease, the survival rate at 5 years is of about 90% (stage I). The most important risk factors for this tumor are alcohol and tobacco consumption and these patients, probably because of their lifestyle, have several associated comorbidities. Objectives: To frame the survival rates related to the disease, not disease related and also those arising from other malignancies, allowing to criticize some published data. Methods: From the analysis of medical records of patients diagnosed with laryngeal cancer in stages I and II, treated from 2000 to 2005, the cause of death in these patients was analysed. Results: A total of 216 clinical records were reviewed. It was observed that the overall survival of patients in the study period was 75% and that 66.7% and 54.5% of the deaths were not related to the disease, respectively, for stages I and II. It was also found that the specific survival rate for stage I was 94.6% and for stage II was 90.3%. Conclusion: The results show that most patients’ deaths were not related to laryngeal cancer. Thus, the authors emphasize the importance of a careful analysis of statistical data on rates of survival / mortality for cancers of the larynx, especially in the early stages.Introdução: O carcinoma da laringe é uma das neoplasias mais frequentes na região da cabeça e pescoço e ocorre predominantemente no sexo masculino. O pico da incidência situa-se entre os 50 e os 70 anos de vida. A região glótica é a mais afectada, mas nos países mediterrânicos, estes tumores podem exprimir-se mais na região supraglótica. Nos estádios precoces da doença, a taxa de sobrevivência aos cinco anos é de cerca de 90% (estádio I). Os factores de risco mais importantes para esta neoplasia são o consumo de álcool e de tabaco, sendo que, estes doentes, provavelmente pelo seu estilo de vida, apresentam várias comorbilidades associadas. Objectivo: Enquadrar as taxas de sobrevivência relacionadas com a doença, com as não relacionadas com a doença e ainda as decorrentes de outras neoplasias, permitindo criticar dados estatísticos publicados. Métodos: A partir da análise dos processos clínicos dos doentes com diagnóstico de carcinoma da laringe estádios I e II, tratados entre 2000 e 2005, procurou-se analisar a causa de morte desses doentes. Resultados: Foram consultados os processos clínicos de 216 doentes. Observou-se que a sobrevivência global dos doentes, no período estudado, foi de 75%, sendo que 66,7% e 54,5 % das mortes não estavam relacionadas com a doença, respectivamente, para os estádios I e II. Constatou-se também que a sobrevivência específica para o estádio I foi de 94,6% e para o estádio II de 90,3%. Conclusão: Os resultados obtidos revelam que grande parte das mortes dos doentes não estava relacionada com a neoplasia laríngea. Deste modo, os autores enfatizam a importância de uma criteriosa análise dos dados estatísticos relativos às taxas de sobrevivência / mortalidade para as neoplasias da laringe, especialmente nos estádios precoces.Ordem dos Médicos2012-11-12info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/x-pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293oai:ojs.www.actamedicaportuguesa.com:article/293Acta Médica Portuguesa; Vol. 25 No. 5 (2012): September-October; 317-322Acta Médica Portuguesa; Vol. 25 N.º 5 (2012): Setembro-Outubro; 317-3221646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293/86Matos, José PedroCastro Silva, JoaquimMonteiro, Euricoinfo:eu-repo/semantics/openAccess2022-12-20T10:55:59Zoai:ojs.www.actamedicaportuguesa.com:article/293Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:16:27.310352Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Causes of Death in Patients with Laryngeal Cancer in Stages I and II Causas de Morte nos Doentes com Neoplasia da Laringe nos Estádios I e II |
title |
Causes of Death in Patients with Laryngeal Cancer in Stages I and II |
spellingShingle |
Causes of Death in Patients with Laryngeal Cancer in Stages I and II Matos, José Pedro |
title_short |
Causes of Death in Patients with Laryngeal Cancer in Stages I and II |
title_full |
Causes of Death in Patients with Laryngeal Cancer in Stages I and II |
title_fullStr |
Causes of Death in Patients with Laryngeal Cancer in Stages I and II |
title_full_unstemmed |
Causes of Death in Patients with Laryngeal Cancer in Stages I and II |
title_sort |
Causes of Death in Patients with Laryngeal Cancer in Stages I and II |
author |
Matos, José Pedro |
author_facet |
Matos, José Pedro Castro Silva, Joaquim Monteiro, Eurico |
author_role |
author |
author2 |
Castro Silva, Joaquim Monteiro, Eurico |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Matos, José Pedro Castro Silva, Joaquim Monteiro, Eurico |
description |
Background: Laryngeal carcinoma is one of the most common cancers in the head and neck region and occurs predominantly in males. The peak of incidence is between 50 and 70 years of life. The glottis is the most affected topography, but in the Mediterranean countries the supraglottic region assumes a particular preponderance. In the early stages of the disease, the survival rate at 5 years is of about 90% (stage I). The most important risk factors for this tumor are alcohol and tobacco consumption and these patients, probably because of their lifestyle, have several associated comorbidities. Objectives: To frame the survival rates related to the disease, not disease related and also those arising from other malignancies, allowing to criticize some published data. Methods: From the analysis of medical records of patients diagnosed with laryngeal cancer in stages I and II, treated from 2000 to 2005, the cause of death in these patients was analysed. Results: A total of 216 clinical records were reviewed. It was observed that the overall survival of patients in the study period was 75% and that 66.7% and 54.5% of the deaths were not related to the disease, respectively, for stages I and II. It was also found that the specific survival rate for stage I was 94.6% and for stage II was 90.3%. Conclusion: The results show that most patients’ deaths were not related to laryngeal cancer. Thus, the authors emphasize the importance of a careful analysis of statistical data on rates of survival / mortality for cancers of the larynx, especially in the early stages. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-11-12 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293 oai:ojs.www.actamedicaportuguesa.com:article/293 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/293 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293/86 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/x-pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 25 No. 5 (2012): September-October; 317-322 Acta Médica Portuguesa; Vol. 25 N.º 5 (2012): Setembro-Outubro; 317-322 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130618450149376 |